A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

To determine the maximum tolerated doses (MTDs) and dose-limiting toxicities (DLTs) of pegylated liposomal doxorubicin (PLD), paclitaxel (PCX) and gemcitabine (GEM) combination administered biweekly in patients with advanced solid tumours. Twenty-two patients with advanced-stage solid tumours were t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bozionelou, V, Vamvakas, L, Pappas, P, Agelaki, S, Androulakis, N, Kalykaki, A, Nikolaidou, M, Kentepozidis, N, Giassas, S, Marselos, M, Georgoulias, V, Mavroudis, D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359662/
https://ncbi.nlm.nih.gov/pubmed/17551496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603832
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados